Electronic Healthcare Data Can Be Used With Caution In Observational Safety Studies, FDA Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Guidance advises investigators how to work around limitations of electronic healthcare data; agency does not advocate specific type of study design but notes advantages of new (incident) user design.